COVID-19 Vaccines

Misinformation, distrust in medical providers, politics and experiences during the height of COVID are playing into people’s views of vaccination, experts say.

The new COVID vaccines are designed to keep the shots up to date with the virus, which keeps evolving to evade our immune systems.

If you Google COVID isolation standards, you're likely to get a few different answers. So which one should you follow?

The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.

According to the latest CDC data, only 13% of U.S. children have gotten the new shots and about 22% of U.S. adults have.

Experts are concerned that the number of flu and COVID-19 patients in hospitals could peak at around the same time and strain capacity.

This was the year many people finally exhaled. The pandemic was declared no longer an emergency. But viral threats are still here and there are lessons we haven't learned.

Last year, the CDC reported 6,461 COVID-related deaths in New Jersey, or about five times the number of people who died from the flu in the Garden State.

National data shows COVID-19 levels are moderate. In most of the U.S., levels of other respiratory viruses are low, although RSV is ticking up in some southeastern states.

Katalin Karikó Ph.D. and Dr. Drew Weisman Ph.D. won the 2023 Nobel Prize in Medicine and their colleagues raised a glass to toast it in the hospital lobby.

Karikó and Weissman met by chance in the 1990s while photocopying research papers.

Some people are finding pharmacies still don't have supply of the shots, and others are having insurance coverage troubles. Here's what's going on.

As they prepare to dole out newly updated booster shots, local health workers are trying to incorporate lessons learned from three years’ worth of vaccine campaigns.

The agency’s director is expected to sign off on the panel’s recommendation and the vaccines could be available this week.

The vaccines from Moderna and Pfizer and its partner BioNTech were approved Monday for people 12 and older.